Home › Chronische lymfatische leukemie › District of Columbia › Washington
Chronische lymfatische leukemie klinische studies in Washington, DC
22 studies voor Chronische lymfatische leukemie zoeken deelnemers op locaties in en rond Washington (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
RekruterenFase 1/2
- American Oncology Partners of Maryland Pa, Bethesda · 7 mijl verwijderd
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
RekruterenFase 3
- Center for Cancer and Blood Disorders ( Site 5439), Bethesda · 7 mijl verwijderd
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
RekruterenObservatieonderzoek
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mijl verwijderd
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
RekruterenFase 3
- GC2202 Study Site 111, Bethesda · 7 mijl verwijderd
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
RekruterenFase 3
- Sibley Memorial Hospital, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · 7 mijl verwijderd
A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors
RekruterenFase 3
- American Oncology Partners of Maryland Pa, Bethesda · 7 mijl verwijderd
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
RekruterenFase 3
- Medstar Georgetown University Hospital, Washington D.C.
Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)
RekruterenObservatieonderzoek
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
RekruterenFase 2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
RekruterenFase 3
- American Oncology Partners, PA dba The Center for Cancer and Blood Disorders, Bethesda · 7 mijl verwijderd
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
RekruterenFase 2
- Maryland Oncology Hematology, Silver Spring · 7 mijl verwijderd
Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib
RekruterenVroege fase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
RekruterenFase 3
- American Oncology Partners of Maryland, PA, Bethesda · 7 mijl verwijderd
ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL
RekruterenFase 3
- The Center for Cancer and Blood Disorders-Bethesda, Bethesda · 7 mijl verwijderd
Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias
RekruterenFase 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
RekruterenFase 1
- National Institute of Health, Bethesda · 7 mijl verwijderd
A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
RekruterenFase 2
- American Oncology Partners, PA, Bethesda · 7 mijl verwijderd
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
RekruterenFase 3
- Maryland Oncology Hematology - Silver Spring /ID# 267557, Silver Spring · 7 mijl verwijderd
- Center for Cancer and Blood Disorders-American Oncology Partners of Maryland /ID# 266445, Bethesda · 7 mijl verwijderd
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
RekruterenFase 1
- National Institutes of Health Clinical Center, Bethesda · 7 mijl verwijderd
Chronische lymfatische leukemie studies in andere steden
- Boston, MA31 studies
- Columbus, OH28 studies
- Durham, NC27 studies
- Seattle, WA20 studies
- Rochester, MN18 studies
- New York City, NY18 studies
- Houston, TX17 studies
- Baldwin Park, CA16 studies
- Milwaukee, WI15 studies
- Chicago, IL14 studies
- Cincinnati, OH14 studies
- Nashville, TN13 studies
Andere studies in Washington
- Kanker (alle vormen)58 studies
- Niet-kleincellige longkanker55 studies
- Borstkanker46 studies
- Metastatische kanker43 studies
- Longkanker41 studies
- Prostaatkanker38 studies
- Obesitas33 studies
- Colorectale kanker29 studies
- Cardiovasculaire ziekte28 studies
- Blasenkanker26 studies
- Acute myeloïde leukemie24 studies
- Eierstokkanker23 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.